FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3672411000001101: Vascace 2.5mg tablets (Roche Products Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17543901000001118 Vascace 2.5mg tablets (Roche Products Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17544001000001115 Vascace 2.5mg tablets (Roche Products Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vascace 2.5mg tablets (Roche Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Is a Product containing precisely cilazapril 2.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Is a Cilazapril 2.5mg tablets true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Is a Cilazapril 2.5mg tablets false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has active ingredient Cilazapril false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has active ingredient Cilazapril monohydrate false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Is a Vascace true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilazapril true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has specific active ingredient Cilazapril monohydrate false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has specific active ingredient Cilazapril monohydrate true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) Has basis of strength substance Cilazapril true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vascace 2.5mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Is pack of False Vascace 2.5mg tablets (Roche Products Ltd) Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Roche Products Ltd) 28 tablet 4 x 7 tablets Has AMP True Vascace 2.5mg tablets (Roche Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start